Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Global landscape and genetic regulation of RNA editing in cortical samples from individuals with schizophrenia.

Breen MS, Dobbyn A, Li Q, Roussos P, Hoffman GE, Stahl E, Chess A, Sklar P, Li JB, Devlin B, Buxbaum JD; CommonMind Consortium.

Nat Neurosci. 2019 Sep;22(9):1402-1412. doi: 10.1038/s41593-019-0463-7. Epub 2019 Aug 27.

PMID:
31455887
2.

Differential transcriptional response following glucocorticoid activation in cultured blood immune cells: a novel approach to PTSD biomarker development.

Breen MS, Bierer LM, Daskalakis NP, Bader HN, Makotkine I, Chattopadhyay M, Xu C, Buxbaum Grice A, Tocheva AS, Flory JD, Buxbaum JD, Meaney MJ, Brennand K, Yehuda R.

Transl Psychiatry. 2019 Aug 21;9(1):201. doi: 10.1038/s41398-019-0539-x.

3.

Submandibular gland flap for reconstruction after parotidectomy.

Liang KY, Breen MS, Tracy JC, Vaezi AE.

Laryngoscope. 2019 May 9. doi: 10.1002/lary.28037. [Epub ahead of print]

PMID:
31069823
4.

Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age.

Wingo AP, Dammer EB, Breen MS, Logsdon BA, Duong DM, Troncosco JC, Thambisetty M, Beach TG, Serrano GE, Reiman EM, Caselli RJ, Lah JJ, Seyfried NT, Levey AI, Wingo TS.

Nat Commun. 2019 Apr 8;10(1):1619. doi: 10.1038/s41467-019-09613-z.

5.

Deletion of the KH1 Domain of Fmr1 Leads to Transcriptional Alterations and Attentional Deficits in Rats.

Golden CEM, Breen MS, Koro L, Sonar S, Niblo K, Browne A, Burlant N, Di Marino D, De Rubeis S, Baxter MG, Buxbaum JD, Harony-Nicolas H.

Cereb Cortex. 2019 May 1;29(5):2228-2244. doi: 10.1093/cercor/bhz029.

6.

Modelling PTSD diagnosis using sleep, memory, and adrenergic metabolites: An exploratory machine-learning study.

Breen MS, Thomas KGF, Baldwin DS, Lipinska G.

Hum Psychopharmacol. 2019 Mar;34(2):e2691. doi: 10.1002/hup.2691. Epub 2019 Feb 22.

PMID:
30793802
7.

Immunological biomarkers as indicators for outcome after discontinuation of nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic hepatitis B.

Kranidioti H, Manolakopoulos S, Kontos G, Breen MS, Kourikou A, Deutsch M, Quesada-Del-Bosque ME, Martinez-Nunez RT, Naiyer MM, Woelk CH, Sanchez-Elsner T, Hadziyannis E, Papatheodoridis G, Khakoo SI.

J Viral Hepat. 2019 Jun;26(6):697-709. doi: 10.1111/jvh.13068. Epub 2019 Feb 27.

PMID:
30702196
8.

Temporal proteomic profiling of postnatal human cortical development.

Breen MS, Ozcan S, Ramsey JM, Wang Z, Ma'ayan A, Rustogi N, Gottschalk MG, Webster MJ, Weickert CS, Buxbaum JD, Bahn S.

Transl Psychiatry. 2018 Dec 5;8(1):267. doi: 10.1038/s41398-018-0306-4.

9.

The impact of air exchange rate on ambient air pollution exposure and inequalities across all residential parcels in Massachusetts.

Rosofsky A, Levy JI, Breen MS, Zanobetti A, Fabian MP.

J Expo Sci Environ Epidemiol. 2019 Jun;29(4):520-530. doi: 10.1038/s41370-018-0068-3. Epub 2018 Sep 21.

10.

Gene expression in cord blood links genetic risk for neurodevelopmental disorders with maternal psychological distress and adverse childhood outcomes.

Breen MS, Wingo AP, Koen N, Donald KA, Nicol M, Zar HJ, Ressler KJ, Buxbaum JD, Stein DJ.

Brain Behav Immun. 2018 Oct;73:320-330. doi: 10.1016/j.bbi.2018.05.016. Epub 2018 May 20.

11.

Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment.

White CH, Beliakova-Bethell N, Lada SM, Breen MS, Hurst TP, Spina CA, Richman DD, Frater J, Magiorkinis G, Woelk CH.

Front Immunol. 2018 Apr 12;9:603. doi: 10.3389/fimmu.2018.00603. eCollection 2018.

12.

PTSD Blood Transcriptome Mega-Analysis: Shared Inflammatory Pathways across Biological Sex and Modes of Trauma.

Breen MS, Tylee DS, Maihofer AX, Neylan TC, Mehta D, Binder EB, Chandler SD, Hess JL, Kremen WS, Risbrough VB, Woelk CH, Baker DG, Nievergelt CM, Tsuang MT, Buxbaum JD, Glatt SJ.

Neuropsychopharmacology. 2018 Feb;43(3):469-481. doi: 10.1038/npp.2017.220. Epub 2017 Sep 19.

13.

Parallel changes in serum proteins and diffusion tensor imaging in methamphetamine-associated psychosis.

Breen MS, Uhlmann A, Ozcan S, Chan M, Pinto D, Bahn S, Stein DJ.

Sci Rep. 2017 Mar 2;7:43777. doi: 10.1038/srep43777.

14.

Systematic review of blood transcriptome profiling in neuropsychiatric disorders: guidelines for biomarker discovery.

Breen MS, Stein DJ, Baldwin DS.

Hum Psychopharmacol. 2016 Sep;31(5):373-81. doi: 10.1002/hup.2546. Review.

PMID:
27650405
15.

Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors.

Wood O, Woo J, Seumois G, Savelyeva N, McCann KJ, Singh D, Jones T, Peel L, Breen MS, Ward M, Garrido Martin E, Sanchez-Elsner T, Thomas G, Vijayanand P, Woelk CH, King E, Ottensmeier C; SPARC Consortium.

Oncotarget. 2016 Aug 30;7(35):56781-56797. doi: 10.18632/oncotarget.10788.

16.

Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines.

Breen MS, White CH, Shekhtman T, Lin K, Looney D, Woelk CH, Kelsoe JR.

Pharmacogenomics J. 2016 Oct;16(5):446-53. doi: 10.1038/tpj.2016.50. Epub 2016 Jul 12.

PMID:
27401222
17.

Candidate gene networks and blood biomarkers of methamphetamine-associated psychosis: an integrative RNA-sequencing report.

Breen MS, Uhlmann A, Nday CM, Glatt SJ, Mitt M, Metsalpu A, Stein DJ, Illing N.

Transl Psychiatry. 2016 May 10;6:e802. doi: 10.1038/tp.2016.67.

18.

Computational model of the fathead minnow hypothalamic-pituitary-gonadal axis: Incorporating protein synthesis in improving predictability of responses to endocrine active chemicals.

Breen M, Villeneuve DL, Ankley GT, Bencic D, Breen MS, Watanabe KH, Lloyd AL, Conolly RB.

Comp Biochem Physiol C Toxicol Pharmacol. 2016 May-Jun;183-184:36-45. doi: 10.1016/j.cbpc.2016.02.002. Epub 2016 Feb 12.

PMID:
26875912
19.

Air Pollution Exposure Model for Individuals (EMI) in Health Studies: Evaluation for Ambient PM2.5 in Central North Carolina.

Breen MS, Long TC, Schultz BD, Williams RW, Richmond-Bryant J, Breen M, Langstaff JE, Devlin RB, Schneider A, Burke JM, Batterman SA, Meng QY.

Environ Sci Technol. 2015 Dec 15;49(24):14184-94. doi: 10.1021/acs.est.5b02765. Epub 2015 Nov 12.

PMID:
26561729
20.

Acute psychological stress induces short-term variable immune response.

Breen MS, Beliakova-Bethell N, Mujica-Parodi LR, Carlson JM, Ensign WY, Woelk CH, Rana BK.

Brain Behav Immun. 2016 Mar;53:172-182. doi: 10.1016/j.bbi.2015.10.008. Epub 2015 Oct 22.

PMID:
26476140
21.

Gene networks specific for innate immunity define post-traumatic stress disorder.

Breen MS, Maihofer AX, Glatt SJ, Tylee DS, Chandler SD, Tsuang MT, Risbrough VB, Baker DG, O'Connor DT, Nievergelt CM, Woelk CH.

Mol Psychiatry. 2015 Dec;20(12):1538-45. doi: 10.1038/mp.2015.9. Epub 2015 Mar 10.

22.

Modeling spatial and temporal variability of residential air exchange rates for the Near-Road Exposures and Effects of Urban Air Pollutants Study (NEXUS).

Breen MS, Burke JM, Batterman SA, Vette AF, Godwin C, Croghan CW, Schultz BD, Long TC.

Int J Environ Res Public Health. 2014 Nov 7;11(11):11481-504. doi: 10.3390/ijerph111111481.

23.

GPS-based microenvironment tracker (MicroTrac) model to estimate time-location of individuals for air pollution exposure assessments: model evaluation in central North Carolina.

Breen MS, Long TC, Schultz BD, Crooks J, Breen M, Langstaff JE, Isaacs KK, Tan YM, Williams RW, Cao Y, Geller AM, Devlin RB, Batterman SA, Buckley TJ.

J Expo Sci Environ Epidemiol. 2014 Jul;24(4):412-20. doi: 10.1038/jes.2014.13. Epub 2014 Mar 12.

24.

A review of air exchange rate models for air pollution exposure assessments.

Breen MS, Schultz BD, Sohn MD, Long T, Langstaff J, Williams R, Isaacs K, Meng QY, Stallings C, Smith L.

J Expo Sci Environ Epidemiol. 2014 Nov;24(6):555-63. doi: 10.1038/jes.2013.30. Epub 2013 May 29. Review.

PMID:
23715084
25.

Developing predictive approaches to characterize adaptive responses of the reproductive endocrine axis to aromatase inhibition: II. Computational modeling.

Breen M, Villeneuve DL, Ankley GT, Bencic DC, Breen MS, Watanabe KH, Lloyd AL, Conolly RB.

Toxicol Sci. 2013 Jun;133(2):234-47. doi: 10.1093/toxsci/kft067. Epub 2013 Mar 9.

PMID:
23475784
26.

Epistasis as the primary factor in molecular evolution.

Breen MS, Kemena C, Vlasov PK, Notredame C, Kondrashov FA.

Nature. 2012 Oct 25;490(7421):535-8. doi: 10.1038/nature11510. Epub 2012 Oct 14.

PMID:
23064225
27.

Mechanistic computational model of steroidogenesis in H295R cells: role of oxysterols and cell proliferation to improve predictability of biochemical response to endocrine active chemical--metyrapone.

Breen M, Breen MS, Terasaki N, Yamazaki M, Lloyd AL, Conolly RB.

Toxicol Sci. 2011 Sep;123(1):80-93. doi: 10.1093/toxsci/kfr167. Epub 2011 Jul 1.

PMID:
21725065
28.

Mitochondrial pathogenic mutations are population-specific.

Breen MS, Kondrashov FA.

Biol Direct. 2010 Dec 31;5:68. doi: 10.1186/1745-6150-5-68.

29.

Predicting residential air exchange rates from questionnaires and meteorology: model evaluation in central North Carolina.

Breen MS, Breen M, Williams RW, Schultz BD.

Environ Sci Technol. 2010 Dec 15;44(24):9349-56. doi: 10.1021/es101800k. Epub 2010 Nov 11.

30.

PAVA: physiological and anatomical visual analytics for mapping of tissue-specific concentration and time-course data.

Goldsmith MR, Transue TR, Chang DT, Tornero-Velez R, Breen MS, Dary CC.

J Pharmacokinet Pharmacodyn. 2010 Jun;37(3):277-87. doi: 10.1007/s10928-010-9160-6. Epub 2010 May 22.

PMID:
20495853
31.

Computational model of steroidogenesis in human H295R cells to predict biochemical response to endocrine-active chemicals: model development for metyrapone.

Breen MS, Breen M, Terasaki N, Yamazaki M, Conolly RB.

Environ Health Perspect. 2010 Feb;118(2):265-72. doi: 10.1289/ehp.0901107. Erratum in: Environ Health Perspect. 2011 Jan;119(1):A11.

32.

Endocrine disrupting chemicals in fish: developing exposure indicators and predictive models of effects based on mechanism of action.

Ankley GT, Bencic DC, Breen MS, Collette TW, Conolly RB, Denslow ND, Edwards SW, Ekman DR, Garcia-Reyero N, Jensen KM, Lazorchak JM, Martinović D, Miller DH, Perkins EJ, Orlando EF, Villeneuve DL, Wang RL, Watanabe KH.

Aquat Toxicol. 2009 May 5;92(3):168-78. doi: 10.1016/j.aquatox.2009.01.013. Epub 2009 Feb 10.

PMID:
19261338
33.

MRI-guided thermal ablation therapy: model and parameter estimates to predict cell death from MR thermometry images.

Breen MS, Breen M, Butts K, Chen L, Saidel GM, Wilson DL.

Ann Biomed Eng. 2007 Aug;35(8):1391-403. Epub 2007 Apr 7.

PMID:
17436111
34.

Mechanistic computational model of ovarian steroidogenesis to predict biochemical responses to endocrine active compounds.

Breen MS, Villeneuve DL, Breen M, Ankley GT, Conolly RB.

Ann Biomed Eng. 2007 Jun;35(6):970-81. Epub 2007 Apr 13.

PMID:
17436109
35.

MRI-guided laser thermal ablation: model to predict cell death from MR thermometry images for real-time therapy monitoring.

Breen MS, Butts K, Chen L, Saidel GM, Wilson DL.

Conf Proc IEEE Eng Med Biol Soc. 2004;2:1028-31.

PMID:
17271857
36.

Semiautomatic parametric model-based 3D lesion segmentation for evaluation of MR-guided radiofrequency ablation therapy.

Lazebnik RS, Weinberg BD, Breen MS, Lewin JS, Wilson DL.

Acad Radiol. 2005 Dec;12(12):1491-501.

PMID:
16321737
37.

Three-dimensional comparison of interventional MR radiofrequency ablation images with tissue response.

Breen MS, Lazebnik RS, Nour SG, Lewin JS, Wilson DL.

Comput Aided Surg. 2004;9(5):185-91.

PMID:
16192060
38.
39.

Correcting spatial distortion in histological images.

Breen MS, Lancaster TL, Wilson DL.

Comput Med Imaging Graph. 2005 Sep;29(6):405-17.

PMID:
16006097
40.

Radiofrequency thermal ablation: correlation of hyperacute MR lesion images with tissue response.

Breen MS, Lazebnik RS, Fitzmaurice M, Nour SG, Lewin JS, Wilson DL.

J Magn Reson Imaging. 2004 Sep;20(3):475-86.

PMID:
15332256
41.

Automatic model-based evaluation of magnetic resonance-guided radio frequency ablation lesions with histological correlation.

Lazebnik RS, Breen MS, Lewin JS, Wilson DL.

J Magn Reson Imaging. 2004 Feb;19(2):245-54.

PMID:
14745760
42.

Radio-frequency-induced thermal lesions: subacute magnetic resonance appearance and histological correlation.

Lazebnik RS, Breen MS, Fitzmaurice M, Nour SG, Lewin JS, Wilson DL.

J Magn Reson Imaging. 2003 Oct;18(4):487-95.

PMID:
14508786
43.

Sub-acute changes in lesion conspicuity and geometry following MR-guided radiofrequency ablation.

Lazebnik RS, Weinberg BD, Breen MS, Lewin JS, Wilson DL.

J Magn Reson Imaging. 2003 Sep;18(3):353-9.

PMID:
12938132
44.

Volume registration using needle paths and point landmarks for evaluation of interventional MRI treatments.

Lazebnik RS, Lancaster TL, Breen MS, Lewin JS, Wilson DL.

IEEE Trans Med Imaging. 2003 May;22(5):653-60.

PMID:
12846434
45.

Three-dimensional method for comparing in vivo interventional MR images of thermally ablated tissue with tissue response.

Breen MS, Lancaster TL, Lazebnik RS, Nour SG, Lewin JS, Wilson DL.

J Magn Reson Imaging. 2003 Jul;18(1):90-102.

PMID:
12815644
46.

X-ray computed tomography methods for in vivo evaluation of local drug release systems.

Salem KA, Szymanski-Exner A, Lazebnik RS, Breen MS, Gao J, Wilson DL.

IEEE Trans Med Imaging. 2002 Oct;21(10):1310-6.

PMID:
12585713
47.

Three-dimensional model of lesion geometry for evaluation of MR-guided thermal ablation therapy.

Lazebnik RS, Weinberg BD, Breen MS, Lewin JS, Wilson DL.

Acad Radiol. 2002 Oct;9(10):1128-38.

PMID:
12385507
48.

Supplemental Content

Loading ...
Support Center